Characterization of Multidrug-Resistant Staphylococcus aureus Isolates and Comparison of Methods of Susceptibility to Vancomycin.

S. aureus are among the main bacteria causing problems related to multidrug resistance in nosocomial infections. Therefore, it is necessary to carry out a reliable and rapid diagnosis for the identification of the bacteria and characterization of its susceptibility profile, especially vancomycin, which is an alternative treatment against multidrug-resistant (MDR) S. aureus. Thus, the goal of this study was to characterize isolates of S. aureus regarding the resistance and virulence and to check the susceptibility to vancomycin, through different methods, for comparative purposes. Seventeen antimicrobials were tested to assess the susceptibility profile. It was evaluated the presence of identification (nuc), resistance (mecA and blaZ), biofilm (icaA and icaD) and siderophore (sfaD and sbnD) genes. The susceptibility to vancomycin was evaluated by Minimum Inhibitory Concentration (MIC) by broth microdilution (BMD), E-test, commercial panel (Kit), and Phoenix equipment. Most S. aureus (93,33%) was classified as MDR. These isolates were 100% positive for nuc, mecA, icaA, icaD, and sfaD genes; 96.67% for sbnD and 33.33% for blaZ. In relation to BMD, all methods correctly classified the susceptibility of the isolates; however, regarding the exact MIC value for vancomycin, Phoenix showed agreement of 63.33%, E-test (33.33%) and Kit (26.66%). In conclusion, most of S. aureus was considered MDR. Also, they presented resistance, biofilm production, and siderophores genes, showing the pathogenic potential of these bacteria. Besides, the Phoenix test was considered the most effective, as it presents advantages, such as identification of the microorganism and a greater number of antimicrobials tested at a time.

Bioprospection: in vitro antimicrobial potential of the leaf extract of mycorrhizal guava infected by Meloidogyne enterolobii on Klebsiella pneumoniae.

Guava (Psidium guajava L.), is adapted to tropical and subtropical climates, and, in addition to its nutritional value, has great medicinal potential. One of the medicinal effects is antibacterial, and this can be identified from the phytochemicals present in its various parts, especially the leaf, which contains flavonoids, phenols, and tannins, as well as phytocomposites with antibacterial action. Therefore, the interaction of this plant with arbuscular mycorrhizal fungi and Meloidogyne enterolobii is a biotechnological resource that can increase the production of secondary metabolites so that the guava ethanolic extract is effective against multidrug-resistant bacterial strains. Therefore, the objective of this study was to test the inhibitory action of mycorrhizal guava leaf extract and Meloidogyne enterolobii on strains of Klebsiella pneumoniae carbapenemase. Guava seedlings from cuttings were inoculated with Acaulospora longula, and later with Meloidogyne enterolobii; the leaves were harvested at two maturation times of the plant and placed in an oven. Next, a leaf extract was prepared using ethanol as a solvent. The extract was tested in multidrug-resistant strains of K. pneumoniae carbapenemase from operative wounds using disc diffusion methodology. The plant-AMF-phytonematode interaction positively potentialize the inhibitory action of guava leaf ethanolic extract on multidrug-resistant bacterial strains.